Treatment of Resected Non-Small-Cell Lung Cancer/THE AUTHORS REPLY

Treatment of Resected Non-Small-Cell Lung Cancer/THE AUTHORS REPLY

TO THE EDITOR: In the randomized trial of adjuvant chemotherapy for patients with stage IB or stage II non-small-cell lung cancer reported by [Timothy L. Winton, M.D.] et al. (June 23 issue),1 a statistically significant survival advantage was found overall, but no difference was observed in the sub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2005-10, Vol.353 (14), p.1523
Hauptverfasser: Bria, Emilio, Giannarelli, Diana, Terzoli, Edmondo, Winton, Timothy L
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:TO THE EDITOR: In the randomized trial of adjuvant chemotherapy for patients with stage IB or stage II non-small-cell lung cancer reported by [Timothy L. Winton, M.D.] et al. (June 23 issue),1 a statistically significant survival advantage was found overall, but no difference was observed in the subgroup of patients with stage IB cancer.
ISSN:0028-4793
1533-4406